On October 1, 2020 Boston Scientific Corporation (NYSE: BSX) reported that it will webcast an investor update at the virtual 2020 Transcatheter Cardiovascular Therapeutics (TCT) on Thursday, October 15 from 1:00 – 2:00 p.m. EDT (Press release, Boston Scientific, OCT 1, 2020, View Source [SID1234567861]). Joe Fitzgerald, executive vice president and president, Interventional Cardiology; Michael Jaff, D.O., vice president and chief medical officer, clinical affairs, technology and innovation, Peripheral Interventions; Dr. Ian Meredith, AM, executive vice president and global chief medical officer; and Jeff Mirviss, executive vice president and president, Peripheral Interventions will provide a business update and answer questions from investors about the Boston Scientific cardiovascular portfolio.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On Wednesday, October 28, 2020 Boston Scientific will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2020. The call will begin at 8:00 a.m. EDT, hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the third quarter on October 28 prior to the conference call.

A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.com. The replay will be available beginning approximately one hour following the completion of each event.